Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/4/20 → 6/4/26 |
Funding
- Precision Oncology, LLC (Prot #IMGN632-0802 // Prot #IMGN632-0802)
- ImmunoGen, Inc. (Prot #IMGN632-0802 // Prot #IMGN632-0802)
Prot #IMGN632-0802: A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia
- Altman, Jessica K (PD/PI)
Project: Research project